Key statistics
On Friday, Nuvalent Inc (NUVL:NSQ) closed at 100.82, -10.79% below its 52-week high of 113.02, set on Jan 22, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 102.02 |
|---|---|
| High | 104.21 |
| Low | 98.50 |
| Bid | 40.86 |
| Offer | 108.00 |
| Previous close | 101.33 |
| Average volume | 482.35k |
|---|---|
| Shares outstanding | 77.22m |
| Free float | 68.27m |
| P/E (TTM) | -- |
| Market cap | 7.79bn USD |
| EPS (TTM) | -5.32 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Nuvalent to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
- Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026 Milestones
- Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Nuvalent Appoints Ron Squarer to Board of Directors
- Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders
- Nuvalent Announces FDA Acceptance of New Drug Application for Zidesamtinib for the Treatment of TKI Pre-treated Patients with Advanced ROS1-positive NSCLC
More ▼
